CLINICAL_TRIALS
trial_result
· 2024-12-10
Clinical Trial Update: GKT137831 in IPF Patients with Idiopathic Pulmonary Fibrosis [Phase 2]
Summary
Phase 2 trial of GKT137831 in idiopathic pulmonary fibrosis has completed, per the update from the University of Alabama at Birmingham.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Alabama at Birmingham | Conditions: Idiopathic Pulmonary Fibrosis | Phase 2 | Status: COMPLETED